Residency · ATLANTA, GA
Sponsored by Emory University School of Medicine
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Lancet (London, England) · 2022 · 396 citations · John Wells
Foodborne Illness Acquired in the United States-Major Pathogens, 2019.
Emerging infectious diseases · 2025 · 97 citations · Beau Bruce
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Ophthalmology · 2024 · 135 citations · John Wells
Progression of Myopia in School-Aged Children After COVID-19 Home Confinement.
JAMA ophthalmology · 2021 · 335 citations · Jiaxing Wang
Diagnosis and classification of optic neuritis.
The Lancet. Neurology · 2022 · 271 citations · Valerie Biousse
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
JAMA ophthalmology · 2023 · 118 citations · Phoebe Lenhart
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.
JAMA ophthalmology · 2025 · 90 citations · Cecilia Lee
Gene Editing for CEP290-Associated Retinal Degeneration.
The New England journal of medicine · 2024 · 165 citations · Steven Bailey